193 related articles for article (PubMed ID: 24206639)
1. Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial.
Demant KM; Almer GM; Vinberg M; Kessing LV; Miskowiak KW
Trials; 2013 Nov; 14():378. PubMed ID: 24206639
[TBL] [Abstract][Full Text] [Related]
2. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.
Ott CV; Vinberg M; Bowie CR; Christensen EM; Knudsen GM; Kessing LV; Miskowiak KW
Trials; 2018 Sep; 19(1):487. PubMed ID: 30208971
[TBL] [Abstract][Full Text] [Related]
3. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
Trials; 2010 Oct; 11():97. PubMed ID: 20942940
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
[TBL] [Abstract][Full Text] [Related]
5. Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial.
Demant KM; Vinberg M; Kessing LV; Miskowiak KW
PLoS One; 2015; 10(6):e0127955. PubMed ID: 26070195
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.
Xu G; Lin K; Rao D; Dang Y; Ouyang H; Guo Y; Ma J; Chen J
J Affect Disord; 2012 Feb; 136(3):328-39. PubMed ID: 22169253
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
[TBL] [Abstract][Full Text] [Related]
9. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial.
Lewandowski KE; Sperry SH; Ongur D; Cohen BM; Norris LA; Keshavan MS
Trials; 2016 Mar; 17(1):136. PubMed ID: 26969299
[TBL] [Abstract][Full Text] [Related]
10. Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder.
Macoveanu J; Demant KM; Vinberg M; Siebner HR; Kessing LV; Miskowiak KW
J Psychopharmacol; 2018 Oct; 32(10):1075-1085. PubMed ID: 29969938
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual.
Tsapekos D; Strawbridge R; Cella M; Goldsmith K; Kalfas M; Taylor RH; Swidzinski S; Marwaha S; Grey L; Newton E; Shackleton J; Harrison PJ; Browning M; Harmer C; Hartland H; Cousins D; Barton S; Wykes T; Young AH
BMC Psychiatry; 2023 Nov; 23(1):842. PubMed ID: 37968619
[TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits in bipolar disorders: Implications for emotion.
Lima IMM; Peckham AD; Johnson SL
Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
[TBL] [Abstract][Full Text] [Related]
13. The Cognitive Remediation in Bipolar (CRiB) pilot study: study protocol for a randomised controlled trial.
Strawbridge R; Fish J; Halari R; Hodsoll J; Reeder C; Macritchie K; McCrone P; Wykes T; Young AH
Trials; 2016 Jul; 17():371. PubMed ID: 27472964
[TBL] [Abstract][Full Text] [Related]
14. Cognitive-behavioral rehabilitation vs. treatment as usual for bipolar patients: study protocol for a randomized controlled trial.
Gomes BC; Rocca CC; Belizario GO; Lafer B
Trials; 2017 Mar; 18(1):142. PubMed ID: 28351410
[TBL] [Abstract][Full Text] [Related]
15. Memory performance predicts response to psychotherapy for depression in bipolar disorder: A pilot randomized controlled trial with exploratory functional magnetic resonance imaging.
Deckersbach T; Peters AT; Shea C; Gosai A; Stange JP; Peckham AD; Ellard KK; Otto MW; Rauch SL; Dougherty DD; Nierenberg AA
J Affect Disord; 2018 Mar; 229():342-350. PubMed ID: 29331692
[TBL] [Abstract][Full Text] [Related]
16. Clinical and cognitive factors affecting psychosocial functioning in remitted patients with bipolar disorder.
Konstantakopoulos G; Ioannidi N; Typaldou M; Sakkas D; Oulis P
Psychiatriki; 2016; 27(3):182-191. PubMed ID: 27837572
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in remission in bipolar affective disorder.
Rubinsztein JS; Michael A; Paykel ES; Sahakian BJ
Psychol Med; 2000 Sep; 30(5):1025-36. PubMed ID: 12027040
[TBL] [Abstract][Full Text] [Related]
18. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial.
Moreno-Alcázar A; Radua J; Landín-Romero R; Blanco L; Madre M; Reinares M; Comes M; Jiménez E; Crespo JM; Vieta E; Pérez V; Novo P; Doñate M; Cortizo R; Valiente-Gómez A; Lupo W; McKenna PJ; Pomarol-Clotet E; Amann BL
Trials; 2017 Apr; 18(1):160. PubMed ID: 28376919
[TBL] [Abstract][Full Text] [Related]
19. Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients.
Mur M; Portella MJ; Martinez-Aran A; Pifarre J; Vieta E
Psychopathology; 2009; 42(3):148-56. PubMed ID: 19276630
[TBL] [Abstract][Full Text] [Related]
20. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
